TY  - JOUR
T1  - A question of the clinical relevance of determining thrombomodulin level while receiving anticoagulant therapy
AU  - Nguyen C, Chan G, Su M
Y1  - 2009/11/23
N1  - 10.1001/archinternmed.2009.422
JO  - Archives of Internal Medicine
SP  - 2031
EP  - 2031
VL  - 169
IS  - 21
N2  - 
We would like to thank Lind et al1 for their study on thrombomodulin as a marker for bleeding complications during warfarin treatment. This longitudinal cohort study demonstrates that patients who have high levels of soluble thrombomodulin (sTM) and are receiving long-term vitamin K antagonist therapy appear to be at higher risk of clinically relevant and major bleeding complications. If validated, such a laboratory test would be of great importance and clinical utility in assessing the risk of long-term vitamin K antagonist therapy.

SN  - 0003-9926
M3  - doi: 10.1001/archinternmed.2009.422
UR  - http://dx.doi.org/10.1001/archinternmed.2009.422
ER  -